Search

Search results

Save the Date: BioVaria 2022 - Live in Munich & Virtual

BioVaria will take place in a hybrid format on May 11 and 12, 2022 - live at the Sofitel in Munich and virtually. 14 technology transfer partners from five European countries will present more than 50 commercially attractive licensing opportunities. Application for the Startup Pitch & Partner programme is now open until March 1, 2022.

Leading figures from industry, technology transfer, science and the start-up scene are looking forward to meeting again in person at BioVaria 2022, which will take place in a hybrid format on May 11 and 12, 2022 - live at the Sofitel in Munich and virtually. The portfolio includes around 50 innovative projects from all over Europe - therapeutic and diagnostic approaches as well as platform technologies - and selected startups. Many of them will be presented for the first time to a larger business audience at BioVaria.

With technology and startup pitches as well as an all-day poster exhibition, BioVaria is designed for interaction and partnering. Participants can discover numerous valuable opportunities, network and deepen (existing) contacts. For the first time, there will also be the possibility to arrange appointments to continue discussions at the follow-on partnering session, which will take place online the week following BioVaria.

BioVaria's Startup Pitch & Partner program has been a special highlight for years. Investors will have the chance to learn about promising young European start-up projects. These in turn meet first-class investors and industry representatives interested in early projects. The 15 best startups will have the chance to pitch their project live on the BioVaria stage for a chance to win the BioVaria Award. In the subsequent speed dating, they can also personally convince investors of their business idea.

BioVaria is organized by Ascenion and other technology transfer companies.

 

Save the date!

Applications for the Startup Pitch & Partner program will be accepted until March 1, 2022.